Foster & Motley »

Vertex Pharmaceuticals Incorporated shares owned by Foster & Motley

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Foster & Motley from 13F filings

Historical chart of Foster & Motley investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Foster & Motley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Foster & Motley

Quarter filed Position value Share count Share price at filing
2026-06-30 $206k 414 497.58
2025-06-30 $201k 451 445.68
2025-03-31 $219k 451 485.59
2024-09-30 $208k 447 465.32
2024-06-30 $216k 460 469.57
2023-06-30 $201k 572 351.40

More positions owned by Foster & Motley

Schwab Fundamental Intl Lg Co ETF Etf (FNDF)
Schwab International Equity ETF Etf (SCHF)
Janus Henderson Mortgage-Backed ETF Etf (JMBS)
Apple (AAPL)
Vanguard Intl Hi Div Yld Idx ETF Etf (VYMI)
Avantis Emerging Markets Equity ETF Etf (AVEM)
Schwab Fundamental Emerg Mkts Lg Co ETF Etf (FNDE)
Avantis International Equity ETF Etf (AVDE)
Cambria Emerging Shareholder Yield ETF Etf (EYLD)
Hartford Multifactor Developed Markets ETF Etf (RODM)
Alphabet Inc Class C cs (GOOG)
Schwab Intermediate-Term U.S. Trsy ETF Etf (SCHR)
Microsoft Corporation (MSFT)
Janus Henderson AAA CLO ETF Etf (JAAA)
Vanguard Reit Index ETF Etf (VNQ)

View all positions for Foster & Motley

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated